Search
brinzolamide (Azopt)
Tradename: Azopt
Indications:
- increased intraocular pressure
- glaucoma (may be used concurrently with other glaucoma medications)
Contraindications:
- hypersensitivity to brinzolamide, sulfonamide
Pregnancy category: C
Dosage: 1 drop in affected eye TID Suspension, ophthalmic 1%, (5 mL, 10 mL, 15 mL) contains benzalkonium chloride
Storage:
- 4-30 degrees C (39-86 degrees F)
Pharmacokinetics:
- ophthalmic absorbed systemically
- distributes to erythrocytes
- 1/2life in erythrocytes 111 days
- metabolite N-desmethylbrinzolamide accumulates in erythrocytes
Adverse effects:
1) not common (1-10%)
- dermatitis, taste disturbance, blurred vision, blepharitis, foreign body senstation eye, eye pain, eye itching dysgeusia, xerophthalmia, headache, hyperemia, ocular discharge, ocular keratitis, rhinitis
2) uncommon (< 1%)
- allergic reactions, alopecia, conjunctivitis, diplopia, chest pain, diarrhea, dizziness, xerostomia, dyspnea, dyspepsia, eye fatigue, hypertonia, keratoconjunctivitis, keratopathy, kidney pain, nausea, pharyngitis, tearing, urticaria, eyelid margin crusting or sticky sensation
3) other
- dysuria ?, hyperglycemia ?
- acetazolamide, another carbonic anhydrase inhibitor, may be associated with dysuria, hyperglycemia
Drug interactions:
1) concurrent use of other carbonic anhydrase inhibitors
2) high dose salicylates in combination may result in renal toxicity
Mechanism of action:
- carbonic anhydrase inhibitor
- inhibition of carbonic anhydrase in the ciliary body of the eye decreases aqueous humor production, presumably by reducing formation of bicarbonate with reduction of Na+ & fluid transport, thus reducing intraocular pressure
- intraocular pressure reduction of 4-5 mm Hg when used TID (similar to dorzolamide) [3]
Interactions
drug adverse effects of diuretics
monitor with carbonic anhydrase inhibitors
General
carbonic anhydrase inhibitor
ophthalmic agent (eyedrops)
Database Correlations
PUBCHEM cid=68844
References
- UpToDate 13.3
http://www.utdol.com
LexiComp Drug Information
- MedlinePlus: Brinzolamide Ophthalmic
http://www.nlm.nih.gov/medlineplus/druginfo/meds/a601233.html
- Highlights of Prescribing Information
Azopt. (brinzolamide ophthalmic suspension 1%)
Alcon. A Novartis Co.
Component-of
brimonidine/brinzolamide (Simbrinza)